share_log

華領醫藥-B:自願性公告 - 全球首創新藥葡萄糖激酶激活劑华堂宁獲納入2023年國家醫保藥品目錄

HUA MEDICINE-B: VOLUNTARY ANNOUNCEMENT - INNOVATIVE FIRST-IN-CLASS GKA, HUATANGNING INCLUDED IN THE 2023 NATIONAL REIMBURSEMENT DRUG LIST

香港交易所 ·  Dec 13, 2023 05:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more